Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV–driven sinusoidal remodeling
Can Gan, Usman Yaqoob, Jianwen Lu, Man Xie, Abid Anwar, Nidhi Jalan-Sakrikar, Sofia Jerez, Tejasav S. Sehrawat, Amaia Navarro-Corcuera, Enis Kostallari, Nawras W. Habash, Sheng Cao, Vijay H. Shah
Can Gan, Usman Yaqoob, Jianwen Lu, Man Xie, Abid Anwar, Nidhi Jalan-Sakrikar, Sofia Jerez, Tejasav S. Sehrawat, Amaia Navarro-Corcuera, Enis Kostallari, Nawras W. Habash, Sheng Cao, Vijay H. Shah
View: Text | PDF
Research Article Cell biology Hepatology

Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV–driven sinusoidal remodeling

  • Text
  • PDF
Abstract

Portal hypertension (PHTN) is a severe complication of liver cirrhosis and is associated with intrahepatic sinusoidal remodeling induced by sinusoidal resistance and angiogenesis. Collagen type IV (COL4), a major component of basement membrane, forms in liver sinusoids upon chronic liver injury. However, the role, cellular source, and expression regulation of COL4 in liver diseases are unknown. Here, we examined how COL4 is produced and how it regulates sinusoidal remodeling in fibrosis and PHTN. Human cirrhotic liver sample RNA sequencing showed increased COL4 expression, which was further verified via immunofluorescence staining. Single-cell RNA sequencing identified liver sinusoidal endothelial cells (LSECs) as the predominant source of COL4 upregulation in mouse fibrotic liver. In addition, COL4 was upregulated in a TNF-α/NF-κB–dependent manner through an epigenetic mechanism in LSECs in vitro. Indeed, by utilizing a CRISPRi-dCas9-KRAB epigenome-editing approach, epigenetic repression of the enhancer-promoter interaction showed silencing of COL4 gene expression. LSEC-specific COL4 gene mutation or repression in vivo abrogated sinusoidal resistance and angiogenesis, which thereby alleviated sinusoidal remodeling and PHTN. Our findings reveal that LSECs promote sinusoidal remodeling and PHTN during liver fibrosis through COL4 deposition.

Authors

Can Gan, Usman Yaqoob, Jianwen Lu, Man Xie, Abid Anwar, Nidhi Jalan-Sakrikar, Sofia Jerez, Tejasav S. Sehrawat, Amaia Navarro-Corcuera, Enis Kostallari, Nawras W. Habash, Sheng Cao, Vijay H. Shah

×

Figure 9

Epigenetic repression of LSEC-derived COL4 alleviates PHTN.

Options: View larger image (or click on image) Download as PowerPoint
Epigenetic repression of LSEC-derived COL4 alleviates PHTN.
(A) Schemati...
(A) Schematic of dCas9-KRAB Cdh5CreERT2 mice undergoing tamoxifen injection, AAV delivery, and PHTN establishment. (B) CCl4 administration increased portal pressure by 70% in mice with control AAV (AAV-non) delivery, whereas this increase was abrogated by 25% to 30% in mice with AAV-sg4 or AAV-sg5 (n = 5–6/group). (C) Representative IF staining showed that increased COL4 expression in liver sinusoids after CCl4 injection was blocked in mice treated with AAV-sg4 or AAV-sg5 (n = 5/group). (D) Representative IHC staining of liver tissues showed a significant increase in sinusoidal Cd34 level in mice that underwent CCl4 administration and were treated with AAV-non versus with AAV-sg4 or AAV-sg5 (n = 5/group). (E and F) After 6 weeks of CCl4 administration, LSECs were isolated for qPCR analysis. Decreased expression of Col4a1 and Col4a2 (E), as well as decreased expression of Cd34 (F), were noted in mice with AAV-sg4 or AAV-sg5 delivery (n = 3/group). Scale bars: 20 μm (C), 100 μm (D). Graphs represent mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA followed by Bonferroni’s posttest.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts